)
Visual
test
Sanara MedTech
Sanara MedTech (SMTI) investor relations material
Sanara MedTech Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary12 Nov, 2025
Executive summary
Net revenue for Q3 2025 increased 22% year-over-year to $26.3 million, driven by strong sales of soft tissue repair products, especially CellerateRX Surgical and BiOSurge, and expansion into new healthcare facilities and distribution networks.
Discontinued the THP segment after a strategic review due to persistent losses and lack of investor interest, resulting in a $26.5 million noncash asset impairment charge and reclassification as discontinued operations.
Net income from continuing operations was $0.8 million in Q3 2025, reversing a net loss of $0.2 million in Q3 2024; Adjusted EBITDA rose to $4.9 million from $2.6 million.
Expanded distributor network to over 400 and increased healthcare facility customers to more than 1,400, with significant runway for further penetration.
Leadership transition with Seth Yon appointed President and CEO, succeeding Ron Nixon.
Financial highlights
Q3 2025 gross profit was $24.5 million, up 24% year-over-year, with gross margin improving to 93%.
Operating income for Q3 2025 was $2.9 million, a 278% increase year-over-year.
Adjusted EBITDA for Q3 2025 was $4.9 million, up from $2.6 million in Q3 2024; for the first nine months, Adjusted EBITDA was $12.3 million, up from $5.1 million.
Net cash provided by operating activities in Q3 2025 was $2.2 million; for the first nine months, $2.8 million.
Trailing 12-month net revenue reached nearly $102 million, up 31% year-over-year.
Outlook and guidance
Management expects continued strong, sustainable revenue growth and improved profitability for the remainder of 2025 and beyond, focusing on operational efficiency and investment in the surgical business.
Sufficient liquidity is expected for at least the next 12 months, with $14.9 million cash on hand and $12.25 million available under the CRG Term Loan as of September 30, 2025.
No material cash spend anticipated for THP after 2025; focus remains on profitable growth and operating leverage.
How does THP's exit improve core business profitability
What is the plan for the $12.25M borrowing capacity
What commercial strategies drive soft tissue product growth
How does THP discontinuation enhance core ops?
What drives sustained growth beyond Q4 2025?
Identify key areas for future margin expansion?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next Sanara MedTech earnings date
Q4 202525 Mar, 2026
Sanara MedTech
Next Sanara MedTech earnings date
Q4 202525 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Sanara MedTech Inc is a medical technology company that develops and markets wound care and surgical products. The company provides advanced therapies for chronic and acute wound management, with products distributed through hospitals, clinics, and outpatient facilities. Sanara MedTech Inc is headquartered in Fort Worth, Texas, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage